Chemistry Wealth Management LLC raised its stake in shares of T. Rowe Price Capital Appreciation Equity ETF (NYSEARCA:TCAF – Free Report) by 8.8% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 155,089 shares of the company’s stock after purchasing an additional 12,562 shares during the period. T. Rowe Price Capital Appreciation Equity ETF accounts for 1.2% of Chemistry Wealth Management LLC’s portfolio, making the stock its 16th largest position. Chemistry Wealth Management LLC owned about 0.11% of T. Rowe Price Capital Appreciation Equity ETF worth $5,472,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Farther Finance Advisors LLC boosted its stake in shares of T. Rowe Price Capital Appreciation Equity ETF by 612.5% in the first quarter. Farther Finance Advisors LLC now owns 1,995 shares of the company’s stock valued at $65,000 after purchasing an additional 1,715 shares during the period. Ameriflex Group Inc. bought a new position in T. Rowe Price Capital Appreciation Equity ETF during the 4th quarter valued at $153,000. United Advisor Group LLC bought a new position in T. Rowe Price Capital Appreciation Equity ETF during the 1st quarter valued at $210,000. Kovack Advisors Inc. bought a new position in T. Rowe Price Capital Appreciation Equity ETF during the 1st quarter valued at $222,000. Finally, Hopwood Financial Services Inc. boosted its stake in T. Rowe Price Capital Appreciation Equity ETF by 13.8% during the 1st quarter. Hopwood Financial Services Inc. now owns 7,021 shares of the company’s stock valued at $227,000 after acquiring an additional 850 shares during the last quarter.
T. Rowe Price Capital Appreciation Equity ETF Stock Down 0.3%
Shares of NYSEARCA:TCAF opened at $36.99 on Monday. The company has a market cap of $5.26 billion, a PE ratio of 29.44 and a beta of 0.91. The company’s 50-day moving average price is $36.47 and its 200 day moving average price is $34.10. T. Rowe Price Capital Appreciation Equity ETF has a fifty-two week low of $28.28 and a fifty-two week high of $37.12.
About T. Rowe Price Capital Appreciation Equity ETF
The T. Rowe Price Capital Appreciation Equity ETF (TCAF) is an exchange-traded fund. The fund’s investment portfolio concentrates primarily on large cap equity. TCAF is an actively managed fund that pursues higher quality stocks of US large-cap companies that are perceived to have above average potential for capital growth.
Read More
- Five stocks we like better than T. Rowe Price Capital Appreciation Equity ETF
- Insider Trades May Not Tell You What You Think
- Wall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall
- Growth Stocks: What They Are, What They Are Not
- Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Football Season Is Here and DraftKings Stock Is Surging
Want to see what other hedge funds are holding TCAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for T. Rowe Price Capital Appreciation Equity ETF (NYSEARCA:TCAF – Free Report).
Receive News & Ratings for T. Rowe Price Capital Appreciation Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T. Rowe Price Capital Appreciation Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.